National Heart, Lung and Blood Institute (NHLBI) Clinical Study

Stem Cell Transplantation for Older Patients with Leukemia, Lymphoma, and MDS

NHLBI is recruiting patients for a new transplant protocol aimed at older individuals (55-75 years of age) with hematological malignancies.

Eligibility:
55-75 years of age Available
HLA-identical sibling donor

Diseases to be included:

• High-risk MDS (greater than or equal to 5% blasts, unfavorable cytogenetics, treatment-related disease, CMML)
• AML (complete or partial remission)
• ALL (complete or partial remission)
• CML - Imatinib (Gleevec)-failures
• Non-Hodgkin's Lymphoma / Hodgkin's lymphoma
• ECOG performance status 0-2

Patients accepted to participate in the clinical research protocol are not asked to pay for hospital or treatment costs at the NIH. For more information, contact Laura Wisch (tel. 301-402-0797, email: wischl@nhlbi.nih.gov).

They're at it Again! Swimathon